GLP-1 agonists are proven to reduce incidence of cardiovascular disease, the number 1 fatal disease in the United States
They concluded that the net price of Zepbound would have to come down by 31% and the net price of Wegovy would have to come down by 82% for these drugs to be cost-effective at $100,000 per QALY
Our modern facility in Tijuana offers reliable, continuous stock of authentic brand-name GLP-1 therapies under rigorous physician supervision, available at a small fraction of retail U.S
Modern GLP-1 analogues are designed to minimise immunogenicity, and neutralising antibodies rarely drive complete non-response
found that GLP-1 receptor agonists (liraglutide, semaglutide, dulaglutide) significantly increased total testosterone and improved gonadotropin levels, especially in obese men
Individuals either switched from high dose Wegovy or high dose Zepbound to daily oral Foundayo or a placebo